[HTML][HTML] Factor Xa inhibition with apixaban does not influence cardiac remodelling in rats with heart failure after myocardial infarction

SR Yurista, HHW Silljé, KT Nijholt, MM Dokter… - … Drugs and Therapy, 2021 - Springer
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction.

SR Yurista, HHW Silljé, KT Nijholt… - … Drugs & Therapy, 2021 - search.ebscohost.com
Background: Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

[PDF][PDF] Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

SR Yurista, HHW Silljé, KT Nijholt, MM Dokter… - 2020 - researchgate.net
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

[HTML][HTML] Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

SR Yurista, HHW Silljé, KT Nijholt… - … Drugs and Therapy, 2021 - ncbi.nlm.nih.gov
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

SH HW, KT Nijholt, MM Dokter… - … Drugs and Therapy, 2021 - search.proquest.com
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction.

SR Yurista, HHW Silljé, KT Nijholt… - … Drugs and Therapy, 2021 - europepmc.org
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

SR Yurista, HHW Silljé, KT Nijholt… - … drugs and therapy, 2021 - pubmed.ncbi.nlm.nih.gov
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

[PDF][PDF] Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

SR Yurista, HHW Silljé, KT Nijholt, MM Dokter… - 2020 - scholar.archive.org
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

S Yurista, H Sillje, K Nijholt, M Dokter… - … Drugs and Therapy, 2021 - research.rug.nl
Background: Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …

[PDF][PDF] Factor Xa inhibition with apixaban does not influence cardiac remodeling in rats with heart failure after myocardial infarction

SR Yurista, HHW Silljé, KT Nijholt… - … effects of non …, 2020 - research.rug.nl
Background: Heart failure (HF) is considered to be a prothrombotic condition and it has been
suggested that coagulation factors contribute to maladaptive cardiac remodelling via …